Vaccination of mice with a modified Vaccinia Ankara (MVA) virus expressing the African horse sickness virus (AHSV) capsid protein VP2 induces virus neutralising antibodies that confer protection against AHSV upon passive immunisation

Our study indicates that MVA-VP2 vaccination induces a highly protective humoral immune response against AHSV.